Our research is at the interface of chemical biology, materials science, and 3D tissue engineering and health technologies. It focuses on three key areas: Organ-specific drug delivery, the autonomous reconstruction of organoids and 3D tissues and the AI-driven development of innovative biomaterials for the 3D bioprinting of entire organs and tissues.